Tecentriq 1200mg/20ml Vial (1 Vial) – Atezolizumab Cancer Immunotherapy Infusion
Tecentriq 1200mg/20ml vial contains atezolizumab, an immunotherapy designed to help the immune system fight cancer cells by targeting the PD-L1 pathway.
- The description claims improved survival outcomes and disease control.
Variants (1)
- Default Title — 9456.28 JOD — In stock
AI Readiness
Good foundation, but some important product data is still missing.
80%